Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Frank

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Communications|May 11, 2017
Actively addressed single pixel full-colour plasmonic displayDaniel Franklin, Russell Frank, Shin-Tson Wu, et al.
Journal of Ovarian Research|January 28, 2023
How to dose follitropin delta for the first insemination cycle according to the ESHRE and ASRM guidelines; a retrospective cohort studySuha Arab, Russell Frank, Jacob Ruiter, et al.
Archives of Gynecology and Obstetrics|January 3, 2021
A comparison of oral versus injectable ovarian stimulation in IUI in women ≥38 years of age with decreased ovarian reserveRussell Frank, Naama Steiner, Maryam Al Shatti, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 3, 2021
Outcomes of donor versus partner sperm in intrauterine insemination in women aged 38 years and olderRussell Frank, Naama Steiner, Maryam Al Shatti, et al.
Archives of Gynecology and Obstetrics|July 5, 2021
Is controlled ovarian stimulation and insemination an effective treatment in older women with male partners with decreased total motile sperm counts?Einav Kadour-Peero, Naama Steiner, Russell Frank, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 24, 2021
Do oral ovulation induction agents offer benefits in women 38 to 43 years of age undergoing insemination cycles?Naama Steiner, Jacob Ruiter-Ligeti, Russell Frank, et al.
Endocrine-Related Cancer|June 12, 2012
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathwayHenning Hvid, Sarah-Maria Fendt, Marie-José Blouin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Communications|May 11, 2017
Actively addressed single pixel full-colour plasmonic displayDaniel Franklin, Russell Frank, Shin-Tson Wu, et al.
Journal of Ovarian Research|January 28, 2023
How to dose follitropin delta for the first insemination cycle according to the ESHRE and ASRM guidelines; a retrospective cohort studySuha Arab, Russell Frank, Jacob Ruiter, et al.
Archives of Gynecology and Obstetrics|January 3, 2021
A comparison of oral versus injectable ovarian stimulation in IUI in women ≥38 years of age with decreased ovarian reserveRussell Frank, Naama Steiner, Maryam Al Shatti, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 3, 2021
Outcomes of donor versus partner sperm in intrauterine insemination in women aged 38 years and olderRussell Frank, Naama Steiner, Maryam Al Shatti, et al.
Archives of Gynecology and Obstetrics|July 5, 2021
Is controlled ovarian stimulation and insemination an effective treatment in older women with male partners with decreased total motile sperm counts?Einav Kadour-Peero, Naama Steiner, Russell Frank, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 24, 2021
Do oral ovulation induction agents offer benefits in women 38 to 43 years of age undergoing insemination cycles?Naama Steiner, Jacob Ruiter-Ligeti, Russell Frank, et al.
Endocrine-Related Cancer|June 12, 2012
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathwayHenning Hvid, Sarah-Maria Fendt, Marie-José Blouin, et al.
Pageof 1